Showing results (11-20 of 1,370) with videos related to

Sort By:
Pageof 137
Drug Development Research|February 23, 2016
Epigenetic Treatment of Neuropsychiatric Disorders: Autism and SchizophreniaWalter H Moos, Eleni Maneta, Carl A Pinkert, et al.
Drug Development Research|January 16, 2016
Antiarthritis Effect of Morin is Associated with Inhibition of Synovial AngiogensisNi Zeng, Bei Tong, Xinyu Zhang, et al.
Drug Development Research|January 15, 2016
Synthesis of p-O-Alkyl Salicylanilide Derivatives as Novel EGFR InhibitorsLi Zhang, Lin Hou, Wenyan Sun, et al.
Drug Development Research|April 5, 2016
Antinociceptive Interactions Between Meloxicam and Gabapentin in Neuropathic Pain Depend on the Ratio used in Combination in RatsJosué Vidal Espinosa-Juárez, Osmar Antonio Jaramillo-Morales, Janette Nallely Corona-Ramos, et al.
Drug Development Research|August 5, 2016
Apocynin Suppresses Lipopolysaccharide-Induced Inflammatory Responses Through the Inhibition of MAP Kinase Signaling Pathway in RAW264.7 CellsYoung-Jae Hwang, Sung Joon Lee, Jin-Young Park, et al.
Drug Development Research|August 12, 2016
Protective Effect of Metformin against Acute Inflammation and Oxidative Stress in RatAbhimanu Pandey, Vijay L Kumar
Drug Development Research|February 11, 2025
Reviewing on AI-Designed Antibiotic Targeting Drug-Resistant Superbugs by Emphasizing Mechanisms of ActionZafer Yönden, Samira Reshadi, Ahmad Farrokh Hayati, et al.
Drug Development Research|February 6, 2025
RETRACTION: to "Oleanolic Acid Reduces Oxidative Stress and Neuronal Apoptosis After Experimental Subarachnoid Hemorrhage by Regulating Nrf2/HO-1 Pathway"
Drug Development Research|January 12, 2025
Naringenin Inhibits Ferroptosis in Renal Tubular Epithelial Cells of Diabetic Nephropathy Through SIRT1/FOXO3a Signaling PathwayYi Zhou, Tianchi Hu, Huarong Zeng, et al.
Drug Development Research|January 17, 2025
A Real-World Disproportionality Analysis of Histamine H2-Receptors Antagonists (Famotidine): A Pharmacovigilance Study Based on Spontaneous Reports in the FDA Adverse Event Reporting SystemDongdong Zhang, Ying Cai, Yixin Sun, et al.
Pageof 137